Search company, investor...

TcLand

tcland-biotech.com

Founded Year

2002

Stage

Unattributed VC | Alive

Total Raised

$10.8M

Last Raised

$10.8M | 15 yrs ago

About TcLand

TcLand Expression is a provider in the field of gene expression biomarkers in immunology

Headquarters Location

CHU Hotel Dieu 30 Boulevard Jean Monnet

France

Missing: TcLand's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: TcLand's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing TcLand

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TcLand is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest TcLand News

TcLand Expression Product Pipeline Analysis 2017 Update Report Updated 14072017 Prices from USD $750

Aug 21, 2017

Home » Topics » Transplantation » Latest News » TcLand Expression Product Pipeline Analysis, 2017 Update [Report Updated: 14072017] Prices from USD $750 Summary TcLand Expression TcLand is a developer of companion diagnostics in immune mediated disorders and biomarkers in solid organ transplantation . The company develops companion diagnostics based on its gene expression biomarkers platform. Its research and development platform develops and validates invasive multigenes molecular diagnostic blood tests. TcLand's clinical development programs include RAINFDx Test, IMD Dx2, IMD Dx3 and LTolX test. The company also offers liver transplantation and rheumatoid arthritis services. It partners with pharma and biotech companies for the development of companion diagnostics. TcLand is headquartered in Mulhouse, France. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company TcLand Expression The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Related Biotechnology, Pharmaceutical and Healthcare News

TcLand Frequently Asked Questions (FAQ)

  • When was TcLand founded?

    TcLand was founded in 2002.

  • What is TcLand's latest funding round?

    TcLand's latest funding round is Unattributed VC.

  • How much did TcLand raise?

    TcLand raised a total of $10.8M.

  • Who are the investors of TcLand?

    Investors of TcLand include Auriga, Quest for Growth, Genzyme, Inserm Transfert, Beviguen and 3 more.

  • Who are TcLand's competitors?

    Competitors of TcLand include Kemp Proteins, LifeSensors, NMS Group, Actimis Pharmaceuticals, BrightPath Biotherapeutics and 11 more.

Compare TcLand to Competitors

S
Sekmed S.R.L.

Sekmed is a biotechnology company working in the drug discovery and gene hunting field. The company's fishing nets are the company's DC-based bioassays, and the company are looking for catch: drug candidates to create vaccines, improve transplant acceptance and treat autoimmunity.

LifeSensors Logo
LifeSensors

LifeSensors is a biotechnology company located 35 miles west of Philadelphia, Pennsylvania, USA. Founded in 1996, LifeSensors has developed a number of protein expression technologies that enable efficient translation of the genome into proteome.LifeSensors is well-known for its innovations in an important family of proteins consisting of ubiquitin and ubiquitin-like proteins (UBL) such as SUMO (Small Ubiquitin-like MOdifier).LifeSensors has been granted several patents to cover the use of SUMO and other UBLs as gene fusion tags to improve the expression and purification of recombinant proteins. Additional patent applications are in various stages of review. Currently, LifeSensors is expanding its protein production capabilities and is developing protein micro array for drug discovery and diagnostics.

C
CODA Genomics

CODA Genomics aims to take a biology process that normally yields an entire array of unspecific products, and through computer optimization and a step-wise process, directs an assembly of the desired product that is thermodynamically efficient. The company's CODExpress Gene kit aims to allow researchers to express custom proteins in their lab with their own gene constructs and variants.

M
Motia

Primera BioSystems, formerly known as Sention, is developing gene expression analysis assays and instruments for use in research and diagnostic laboratories. The underlying STAR technology (Scalable Trancriptional Analysis Routine) aims to enable combining multiplexing (<20 genes) and real time PCR in a single assay.

Q
Quantum Logic Devices

Welcome to Quantum Logic Devices. We're using nanotechnology to bring together "wet" biology and "dry" semiconductor electronics to create new products to improve healthcare. The company's patented nanoelectronic platforms will accelerate knowledge generation in such fields as genomics, proteomics, and drug discovery. This understanding will produce innovations such as "personalized" drugs and molecular diagnostics that will make the practice of medicine more efficient and more successful. QLD's technology aims to provide direct observation of molecular reactions without optical labels, which greatly aims to simplify bioassay procedures and removes much of the error associated with label-based technologies.

P
Proteopure

Proteomics is widely viewed as the cornerstone of future success in drug discovery and clinical diagnostics, but the complexity of protein molecules and their interactions requires new tools to find and understand biomarkers and protein functions. A critical step in the research process is to properly prepare the molecular sample before analysis can begin. Proteopure, Inc.'s technology is the foundation of a simple laboratory "kit" that fills unmet research needs.nProteopure developed and is now marketing sample protein preparation kits. In addition, Proteopure markets complementary products where there is overlapping customer synergy. These other products include a kit for membrane sample preparation, a kit for measuring protein concentration, fluorescent nanoclusters and beads for labeling proteins, and fluorescent tagged genes for measuring protein expression and location.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.